Even as more signs mount to a funding shortfall for startups, large rounds are still out there to be had from investors. This week saw three rounds announced in the U.S. at more than a quarter-billion dollars. Biotech and fintech both still seem to strike a chord with VCs even as the market softens. READ MORE